All posts by Jonathan Hausmann

I am a pediatric and adult rheumatologist at Boston Children’s Hospital and Beth Israel Deaconess Medical Center. I have an interest in autoinflammatory diseases, medical education, and the role of social media and technology in healthcare.

Autoinflammatory vs. autoimmune….what’s the difference?

Last week during our weekly physician conference,  I discussed a patient with an autoinflammatory disease.  An elderly male, he had a history of recurrent fevers, hives, and elevated inflammatory markers, which had gone untreated for many years.  Eventually, he developed renal amyloidosis (accumulation of amyloid fibers in the kidney causing kidney failure), and was finally referred to rheumatology clinic for further evaluation.  Although he had many of the classic signs and symptoms of an autoinflammatory disease,  his physicians had not recognized it.  Even at  the conference, some physicians were  unaware of these group of diseases.

Autoinflammatory diseases are a newly described set of illnesses that cause systemic inflammation due to problems in the innate immune system.   The innate immune system includes several types of white blood cells such as neutrophils, macrophages, and natural killer cells.  These cells are the first responders to an infection because any one of them is able to recognize common patterns that are present in many types of pathogens (such as the cell wall in a bacteria).  In response to a pathogen, these cells secrete inflammatory molecules (cytokines) that alert other cells of the immune system and get the body ready to fight.

Autoinflammatory diseases are often caused by genetic mutations within the cells of the innate immune system.  These mutations lead to episodes of unprovoked activation of the immune system (production of inflammatory cytokines, recruitment macrophages, neutrophils, etc).  In a sense, the body acts as if an infection were present, even when there is none.  This is why many of the symptoms of autoinflammatory diseases–such as fever, rashes, joint pain–mimic infections, and why these diseases are often difficult to diagnose.  The best characterized autoinflammatory condition is Familial Mediterranean Fever, which causes recurrent, brief attacks (12 to 72 hours) of fever, abdominal pain, chest pain, joint pain, and evidence of inflammation on blood tests.

In contrast, autoimmune diseases arise from problems in the adaptive (humoral) immune system.  The adaptive immune system is more sophisticated than the innate, and  is made up of very specialized B cells and T cells.  Each B and T cell in our body is unique, and is only able to recognize a specific  pathogen.  Thus, it takes much longer for a B or T cell to recognize that a pathogen has invaded the body.  However, once the pathogen is identified, the cell divides and multiplies, leading to a very effective and direct attack on the pathogen.  B cells also produce antibodies, which help to neutralize the pathogen.  Unlike the innate immune system, the humoral immune system develops “memory,” so that it is better able to fight the pathogen when it reencounters it in the future.

In autoimmune diseases such as lupus, the B and T cells of the adaptive immune system lose the ability to differentiate self from non-self.  That is, they start seeing specific organs in the body as foreign (almost as if they were pathogens!), and thus begin to mount an attack against those organs, often leading to organ damage or destruction.  In lupus, B and T cells often target the kidney, lungs, or heart, often leading to damage or destruction of these organs.  However, autoimmune diseases can target almost any organ in the body.  For example, in multiple sclerosis,  cells attack the brain.   In rheumatoid arthritis, the joint is the target organ.  In pemphigus, the body attacks the skin.  For reasons that are still unknown, autoimmune diseases more often affect women, whereas autoinflammatory diseases usually affect both sexes equally.

In the end, I think my patient may have had Muckle-Wells syndrome, an autoinflammatory disease caused by mutations in the NLRP3 gene.  Autoinflammatory disorders are  are still underdiagnosed and poorly understood.  It seems like every month, a new autoinflammatory disease is discovered (take a look at this week’s New England Journal of Medicine).  Furthermore, various pathways that are abnormal in autoinflammatory diseases have been implicated to play a role in  more common diseases such as heart disease and diabetes.  Thus, by understanding these rare disorders, we may gain a better understanding of  diseases that afflict millions of people throughout the world.